+499.5%
MRNA vs COPX
+84.7%
+414.8%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | COPX | Excess | Alpha |
|---|---|---|---|---|
| 1D | -2.2% | -0.6% | -1.6% | -1.8% |
| 7D | +5.5% | -4.0% | +9.5% | +8.0% |
| 30D | +158.7% | +4.5% | +154.2% | +152.5% |
| 3M | +182.1% | +0.8% | +181.3% | +177.4% |
| 6M | +151.8% | +3.2% | +148.6% | +142.6% |
| YTD | +393.6% | +26.7% | +366.8% | +323.8% |
| 1Y | +499.5% | +85.7% | +413.8% | +307.8% |
| All | +499.5% | +84.7% | +414.8% | +307.8% |
Cumulative growth
Daily Returns
Daily percentage return beside COPX.
Daily Out/Under-Performance
Portfolio return minus COPX return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × COPX return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded COPX wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling